Making the undruggable druggable
Unlocking challenging drug targets for the development of next-generation therapeutics
Selected Collaborations
It all starts with the drug target.
The majority of drug targets are so-called membrane proteins, and these are inherently unstable and challenging to investigate. Or so they were, until now.
Our proprietary Salipro® technology stabilizes membrane proteins in their native forms, enabling them to be employed in drug discovery programs for therapeutic antibodies or small molecule drugs. Through our in-house and partnered pipelines, we drive the discovery of novel drugs.
Pushing drug development forward together
We work with top-tier pharma and biotech partners to unlock drug targets for drug development programs.
Pipeline
We are driving forward drug development in our partnered as well as internal pipelines.
News
Salipro to present at the upcoming PEGS Boston Summit
2024-04-24
Salipro Biotech will participate in the upcoming PEGS Boston Summit from 13-17 May.
Our Senior Scientist, Sara Bonetti, and our BD Director, Peter Jahnmatz, will present two posters showcasing exciting new data from novel collaborations on GPCRs and how the Salipro® platform enables the development of next-generation therapeutics.
You are welcome to visit our posters and join us for a chat to learn more!
Salipro Biotech to present at Bio Korea 2024
2024-04-19
Salipro Biotech will participate in Bio Korea 2024 happening from May 8-10, at COEX, in Seoul, as part of the Swedish Biopharma Delegation!
Connect with us at the Nordic Pavilion booth, where our delegate Lorena Galán, Business Development Manager, will be happy to meet and explore opportunities to collaborate within drug discovery against challenging drug targets.
Mark your calendars on May 9 and join the Swedish Biopharma Seminar, where Lorena will showcase the Salipro® technology to advance drug discovery programs against membrane protein targets.
Feel free to book a meeting with us via the Partnering Center.
See you at Bio Korea 2024!
Salipro to participate in the Nordic Health Summit Japan 2024
2024-04-09
Salipro Biotech will be part (virtually) of the Nordic Health Summit Japan 2024 partnering conference taking place in Tokyo, Japan, on April 25.
Book a meeting with us via the partnering platform to discuss the latest advancements on the Salipro® technology and explore potential collaborations within drug discovery against membrane protein targets.
We look forward to connecting with pharma leaders in Japan!